Clinical Trials in Austin

Showing 13381-13400 of 15,205 trials

Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects

NCT01913002

This Phase 1 study is to investigate the effects of higher doses of LX4211 (800 mg and 2000 mg) do not differ from placebo in the mean change in QTcI from Baseline in healthy subjects.

Healthy

Lexicon Pharmaceuticals63 participantsStarted Jul 2013

Austin, Texas, United States

COMPLETEDNA< 1 mile

Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors

NCT00066482

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effect on the body of combining cyclophosphamide with cisplatin, etoposide, and bleomycin in treating children who have newly diagnosed malignant germ cell tumors that are not in the brain and gonads.

Childhood Germ Cell TumorExtragonadal Germ Cell Tumor

Children's Oncology Group19 participantsStarted Jul 2004

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +95 more locations

Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects

Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors

Find Trials by Condition in Austin

High Dose Trial in COPD

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Study of Quadrivalent Influenza Vaccine Among Adults

Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer

Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist

Pericoital Oral Contraception With Levonorgestrel

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction

A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes